Impact of Brokerage Rating on HCP, Inc.(HCP)

Many HCP, Inc.(HCP) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. HCP was Upgraded by Goldman to Buy on Jan 25, 2017. HCP was Resumed by Barclays on Jan 5, 2017 to Equal Weight, Price Target of the shares are set at $32.HCP was Upgraded by Mizuho on Nov 21, 2016 to Buy, Price Target of the shares are set at $32.

Company has reported several Insider transactions to the SEC, on Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at 40.15 per share price.On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at 40.24 per share price.On Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at 39.20 per share price.

HCP Last issued its quarterly earnings results on Feb 13, 2017. The company reported $0.59 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $0.57. The company had revenue of $540.00 million for the quarter, compared to analysts expectations of $546.91 million. The companys revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.80 EPS.

HCP, Inc. (NYSE:HCP) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 3.17 by 12 Brokerage Firm. 1 Wall Street Firms have rated the stock as a strong buys. 9 Brokerage Firms have advised hold. 2 Analysts have rated it as strong sell.

HCP, Inc. (NYSE:HCP): The mean short term price target for HCP, Inc. (NYSE:HCP) has been established at $31.5 per share. The higher price target estimate is at $38 and the lower price target estimate is expected at $29 according to 9 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $2.76

HCP, Inc. (NYSE:HCP) witnessed a decline in the market cap on Tuesday as its shares dropped 1.43% or 0.44 points. After the session commenced at $30.73, the stock reached the higher end at $30.83 while it hit a low of $30.22. With the volume soaring to 2,640,497 shares, the last trade was called at $30.41. The company has a 52-week high of $36.50149. The company has a market cap of $14,231 million and there are 467,971,170 shares in outstanding. The 52-week low of the share price is $23.518768.

Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.

HCP,

For any feedback and suggestions contact author at Michelle.Egan@thefoundersdaily.com

Add Comment